![Gordon F. Beck](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gordon F. Beck
No más puestos en curso
Perfil
Dr. Gordon F.
Beck is Vice President-Business Development at AuraSense Therapeutics LLC.
Dr. Beck was previously employed as a Principal by Gb4bd LLC.
He received his doctorate degree from the University of Aston.
Antiguos cargos conocidos de Gordon F. Beck.
Empresas | Cargo | Fin |
---|---|---|
Gb4bd LLC | Corporate Officer/Principal | - |
Exicure Operating Co.
![]() Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Corporate Officer/Principal | - |
Formación de Gordon F. Beck.
University of Aston | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Exicure Operating Co.
![]() Exicure Operating Co. Pharmaceuticals: MajorHealth Technology Exicure Operating Co. operates as a biopharmaceutical company commercializing spherical nucleic acid constructs as gene regulation and modulation agents for diseases including applications in oncology, dermatology, neurology, and for immune disorders. The SNA constructs allow the use of oligonucleotide-based therapies to treat diseases in a range of tissue types. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in 2011 and is headquartered in Skokie, IL. | Health Technology |
Gb4bd LLC |
- Bolsa de valores
- Insiders
- Gordon F. Beck